Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹3,168.60
Market cap: ₹25,942 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 67.2×Sector 47.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 2 Capacity Expansion 2 Business Update 2 Annual General Meeting 2 Results Update 1 Regulatory Approval 1 Production Started 1 Patent 1 Merger & Restructuring 1 Management Change 1 Financial Results 1 Dividend 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

24 Jul 2026 12:25 IST BSE

Board Meeting Outcome

Acutaas Chemicals Board Meeting Outcome

Acutaas Chemicals approved its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The board meeting concluded on July 24, 2026.

Read the filing ↗